131I-catuximab (Pacific Meinuoke)

N/A

Report date: 2025/01/26 18:01:15

Base Information

Drug Name131I-catuximab (Pacific Meinuoke)
Drug Alias Name131I-CAb1 F(ab')2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAir Force Medical University
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Pacific Minok Biopharmaceutical Co., Ltd.Air Force Medical University
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A